Also known as Emmanuelle Marie Charpentier, Emmanuelle M. Charpentier, E. M. Charpentier, E. Charpentier, Emmanuelle Marie Petitfrère, Emmanuelle M. Petitfrère, Emmanuelle Petitfrère, E. M. Petitfrère
French microbiologist and biochemist (born 1968)
Emmanuelle Charpentier is a French microbiologist and biochemist born in 1968 who is known for her work on CRISPR gene-editing technology. Her research has had major impact on science and medicine by making it possible to edit DNA more precisely and affordably than ever before.
AI-generated from the Wikipedia summary — may contain errors.
Top works
via Open Library + Wikidata
<a href="https://www.last.fm/music/Emmanuelle+Charpentier">Read more on Last.fm</a>
Emmanuelle Marie Charpentier ( French pronunciation: [emanɥɛl maʁi ʃaʁpɑ̃tje]; born 11 December 1968) is a French professor and researcher in microbiology, genetics, and biochemistry. She has served as a director at the Max Planck Institute for Infection Biology in Berlin since 2015. Three years later, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens. In 2020, Charpentier and American biochemist Jennifer Doudna of the University of California, Berkeley, were awarded the Nobel Prize in Chemistry "for the development of a method for genome editing" (through CRISPR). This was the first science Nobel Prize ever won by two women only.
Early life and education
5 total works indexed
· 2012 · cited 15,279x
· 2022 · cited 13,054x
· 2011 · cited 7,665x
· 2018 · cited 7,135x
· 2014 · cited 6,037x
via Crossref · CC0
via Wikiquote · CC BY-SA
via Wikidata · CC0
via Wikidata sitelinks · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).